Target N V Biotech Radius Health, Inc. (RDUS) insider trading activity

Target N V Biotech is > 10% Shareholder of Radius Health, Inc.. Currently has a direct ownership of 0 shares of RDUS, which is worth approximately $0. The most recent transaction as insider was on Aug 11, 2022, when has been sold 8,733,538 shares (Common Stock) at a price of $10.0 per share, resulting in proceeds of $87,335,380. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

TARGET N V BIOTECH Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 11 2022	SELL Disposition due to a tender of shares in a change of control transaction	$87,335,380 $10.0 p/Share	8,733,538 Reduced 100.0%	0 Common Stock
May 18 2022	BUY Open market or private purchase	$2,661,480 $5.57 p/Share	477,824 Added 5.19%	8,733,538 Common Stock
Jan 06 2022	BUY Open market or private purchase	$1,893,000 $6.31 p/Share	300,000 Added 3.51%	8,255,714 Common Stock
Jan 05 2022	BUY Open market or private purchase	$1,575,000 $6.3 p/Share	250,000 Added 3.05%	7,955,714 Common Stock
Sep 29 2021	BUY Open market or private purchase	$1,295,000 $12.95 p/Share	100,000 Added 1.28%	7,705,714 Common Stock
Sep 22 2021	BUY Open market or private purchase	$1,842,000 $12.28 p/Share	150,000 Added 1.93%	7,605,714 Common Stock
Nov 05 2020	BUY Open market or private purchase	$1,426,000 $14.26 p/Share	100,000 Added 1.32%	7,455,714 Common Stock

Also insider at

MTEM

Molecular Templates, Inc. Healthcare

ESPR

Esperion Therapeutics, Inc. Healthcare

> 10% Shareholder

MGNX

MACROGENICS INC Healthcare

> 10% Shareholder

TNV